Drug intelligence / Profile preview

Closone

Development stage
Phase 4
Lead developer
HK inno.N Corporation
Modality
Small Molecules
Administration
Oral
01

Overview

**Closone** is an oral fixed-dose antiplatelet combination of clopidogrel bisulfate and aspirin developed and manufactured by HK inno.N for prevention of atherothrombotic events in patients with coronary artery disease, including after percutaneous coronary intervention. Clopidogrel is a prodrug whose active metabolite irreversibly inhibits the platelet P2Y12 ADP receptor, while aspirin irreversibly inhibits platelet cyclooxygenase and suppresses thromboxane A2 production; together, these complementary mechanisms reduce platelet activation and aggregation. HK inno.N lists Closone as a prescription fixed-dose combination for atherosclerosis and thromboembolism, and Phase 4 studies evaluated its non-inferiority versus separately administered clopidogrel and aspirin after PCI. ([inno-n.com](https://www.inno-n.com/eng/business/medicine/view?bpc_cd=P102&no=301))

Brand names
Closone
Other names
aspirin + clopidogrelclopidogrel + aspirinclopidogrel bisulfate + aspirin
02

Targets

P2Y12 (Purinergic P2Y12 receptor)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Closone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Closone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call